<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01820871</url>
  </required_header>
  <id_info>
    <org_study_id>SMART-DM</org_study_id>
    <nct_id>NCT01820871</nct_id>
  </id_info>
  <brief_title>Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)</brief_title>
  <official_title>A Pilot Study of Self Management Using Application for Chronic Disease Care in Real siTuation (SMART) - DM</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of smartphone application for
      management of type 2 diabetes mellitus (DM).

      Type 2 DM is an almost incurable chronic disease and continuous management is important for
      long-term prognosis. However, patient's compliance to conventional medical intervention is
      generally unsatisfactory and many patients feel difficult to access to the detail medical
      advice for type 2 DM.

      Thus, the investigators developed a smartphone application for giving programed medical
      intervention to patients according to patients data; blood pressure, fasting blood sugar,
      body weight, calorie intake,exercise amount, etc.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fasting serum glucose and HbA1c</measure>
    <time_frame>3months after enrollemnt (day 0-day 90)</time_frame>
    <description>we will check the fasting serum glucose and HbA1C at the day of enrollment (day0)and those at 3months after enrollment (day 90)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>body weight and BMI</measure>
    <time_frame>3months after enrollemnt (day 0-day 90)</time_frame>
    <description>we will check body weight and BMI at the day of enrollment (day0)and those at 3months after enrollment (day 90)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>3months after enrollment (day 0-90)</time_frame>
    <description>we will check the lipid profile (total cholesterol, Triglyceride, LDL/HDL cholesterol)at the day of enrollment (day0)and those at 3months after enrollment (day 90)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>application arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients of application arm have the smartphone application (android) for management of type 2 DM.
The application contains action plans and alarm system for each situation of serum fasting glucose, blood pressure, body weight, exercise amount, calori intake, medication, etc.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients of conventional arm have the booklet for management of type 2 DM. The application contains general medical guideline and knowledge for management of type 2 DM such as,exercise amount, calori intake, medication, etc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self-Management Using Smartphone Application for Type2 DM</intervention_name>
    <arm_group_label>application arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>self-management using booklet for management type 2 DM</intervention_name>
    <arm_group_label>conventional arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 DM using oral hypoglycemic agent

          -  6.5% &lt; HbA1c &lt; 10%

          -  systolic blood pressure &gt; 130 mmHg or diastolic blood pressure &gt; 80 mmHg

          -  BMI over 23.0

          -  20 &lt; age &lt; 70

          -  smartphone user (android OS based)

        Exclusion Criteria:

          -  Serum fasting glucose &gt; 250 mg/L or post prandial 2 hour serum glucose &gt; 350 mg/L

          -  systolic blood pressure &gt; 180 mmHg or diastolic blood pressure &gt; 110 mmHg

          -  Diabetes mellitus patient using insulin

          -  severe chronic diabetic complications (diabetic foot ulcer, severe diabetic
             retinopathy, diabetic nephropathy with severe proteinuria)

          -  congestive heart failure (NYHA III-IV or left ventricular ejection fraction &lt; 30%)

          -  Aspartate aminotransferase (AST) or alanine transaminase (ALT) over 3 times of upper
             normal limit

          -  Serum creatinine &gt; 1.5 mg/dL

          -  refusal to participate in the study

          -  drug addiction or alcohol addiction

          -  major psychiatric illness

          -  steroid treatment or hormonal treatment with changing the drug or drug dosage in 1
             month

          -  changing dosage of antihypertensive agent, oral hypoglycemic agent or lipid lowering
             agent in 1 month

          -  malignant cancer

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jongha Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haeundae Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>612-030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2013</study_first_submitted>
  <study_first_submitted_qc>March 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2013</study_first_posted>
  <last_update_submitted>November 26, 2013</last_update_submitted>
  <last_update_submitted_qc>November 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Jongha Park</investigator_full_name>
    <investigator_title>Study principal investigator</investigator_title>
  </responsible_party>
  <keyword>T2DM</keyword>
  <keyword>smartphone application</keyword>
  <keyword>serum fasting glucose</keyword>
  <keyword>HbA1c</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

